Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma

Louis Picker, L. J. Medeiros, L. M. Weiss, R. A. Warnke, E. C. Butcher

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

In man, lymphocyte binding to high endothelial venules (HEVs) involves specific 85-95-kd cell surface glycoprotein(s) recognized by the monoclonal antibodies Hermes-1 and Hermes-3. These putative 'homing receptor' molecule(s) are believed to play an important role in the normal regulation of lymphocyte circulation. To investigate the possibility that homing receptors alsy play a role in the biology of lymphoid malignancies, the authors studied over 300 cases of non-Hodgkin's lymphoma by immunohistologic staining with Hermes-1 and -3, antibodies that define two distinct epitopes on the gp 85-95 putative homing receptor molecules. Furthermore, they directly compared expression of the Hermes-3 antigen with clinical extent of disease in 57 patients with diffuse large cell lymphoma. They found that staining of the various subtypes of lymphoma was heterogeneous, and in general correlated with patterns of expression seen in benign lymphoid populations. Essentially all normal lymphoid populations examined, except germinal center B cells and most cortical thymocytes, bear a high level of homing receptor antigen. Similarly, nearly all peripheral T-cell lymphomas, diffuse small cell lymphomas of B lineage, and plasma cell tumors were positive for homing receptor antigen (95%, 97%, and 100% respectively). Small noncleaved cell, follicular, and diffuse large cell lymphomas of B lineage, tumors having morphologic or immunologic features resembling germinal center cells, frequently failed to express Hermes-defined epitopes (81%, 41%, 25% Hermes-3-, respectively). Antigen expression in T-lymphoblastic lymphomas strongly correlated with immunophenotypic subtypes: only 8% of CD4+/CD8+ were Hermes-1+ versus 86% of CD4-/CD8- and 43% of CD4+/CD8-. Hermes-3 expression by cases of diffuse, large cell lymphoma which showed generalized lymph node involvement (a pattern strongly suggestive of HEV-mediated spread; 100% Hermes-3+, mean intensity 3.4) was higher than that of cases with localized or multifocal, contiguous involvement (consistent with lymphatic spread; 69% Hermes-3+, mean intensity 2.2), but these differences did not achieve statistical significance. The results indicate that homing receptor antigen expression, although perhaps necessary for widespread blood-borne lymphoma dissemination to lymphoid sites, is not in and of itself sufficient to predict such behavior in this subtype of lymphoid malignancy.

Original languageEnglish (US)
Pages (from-to)498-504
Number of pages7
JournalAmerican Journal of Pathology
Volume130
Issue number3
StatePublished - 1988
Externally publishedYes

Fingerprint

Lymphocyte Homing Receptors
Antigen Receptors
Lymphoma, Large B-Cell, Diffuse
Non-Hodgkin's Lymphoma
Germinal Center
Venules
Antigens
Epitopes
Lymphoma
Lymphocytes
Staining and Labeling
Peripheral T-Cell Lymphoma
Neoplasms
Follicular Lymphoma
Plasmacytoma
Membrane Glycoproteins
B-Cell Chronic Lymphocytic Leukemia
Thymocytes
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Population

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Picker, L., Medeiros, L. J., Weiss, L. M., Warnke, R. A., & Butcher, E. C. (1988). Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma. American Journal of Pathology, 130(3), 498-504.

Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma. / Picker, Louis; Medeiros, L. J.; Weiss, L. M.; Warnke, R. A.; Butcher, E. C.

In: American Journal of Pathology, Vol. 130, No. 3, 1988, p. 498-504.

Research output: Contribution to journalArticle

Picker, L, Medeiros, LJ, Weiss, LM, Warnke, RA & Butcher, EC 1988, 'Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma', American Journal of Pathology, vol. 130, no. 3, pp. 498-504.
Picker, Louis ; Medeiros, L. J. ; Weiss, L. M. ; Warnke, R. A. ; Butcher, E. C. / Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma. In: American Journal of Pathology. 1988 ; Vol. 130, No. 3. pp. 498-504.
@article{4ff0493cad1a479c96caf92eacabb0ca,
title = "Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma",
abstract = "In man, lymphocyte binding to high endothelial venules (HEVs) involves specific 85-95-kd cell surface glycoprotein(s) recognized by the monoclonal antibodies Hermes-1 and Hermes-3. These putative 'homing receptor' molecule(s) are believed to play an important role in the normal regulation of lymphocyte circulation. To investigate the possibility that homing receptors alsy play a role in the biology of lymphoid malignancies, the authors studied over 300 cases of non-Hodgkin's lymphoma by immunohistologic staining with Hermes-1 and -3, antibodies that define two distinct epitopes on the gp 85-95 putative homing receptor molecules. Furthermore, they directly compared expression of the Hermes-3 antigen with clinical extent of disease in 57 patients with diffuse large cell lymphoma. They found that staining of the various subtypes of lymphoma was heterogeneous, and in general correlated with patterns of expression seen in benign lymphoid populations. Essentially all normal lymphoid populations examined, except germinal center B cells and most cortical thymocytes, bear a high level of homing receptor antigen. Similarly, nearly all peripheral T-cell lymphomas, diffuse small cell lymphomas of B lineage, and plasma cell tumors were positive for homing receptor antigen (95{\%}, 97{\%}, and 100{\%} respectively). Small noncleaved cell, follicular, and diffuse large cell lymphomas of B lineage, tumors having morphologic or immunologic features resembling germinal center cells, frequently failed to express Hermes-defined epitopes (81{\%}, 41{\%}, 25{\%} Hermes-3-, respectively). Antigen expression in T-lymphoblastic lymphomas strongly correlated with immunophenotypic subtypes: only 8{\%} of CD4+/CD8+ were Hermes-1+ versus 86{\%} of CD4-/CD8- and 43{\%} of CD4+/CD8-. Hermes-3 expression by cases of diffuse, large cell lymphoma which showed generalized lymph node involvement (a pattern strongly suggestive of HEV-mediated spread; 100{\%} Hermes-3+, mean intensity 3.4) was higher than that of cases with localized or multifocal, contiguous involvement (consistent with lymphatic spread; 69{\%} Hermes-3+, mean intensity 2.2), but these differences did not achieve statistical significance. The results indicate that homing receptor antigen expression, although perhaps necessary for widespread blood-borne lymphoma dissemination to lymphoid sites, is not in and of itself sufficient to predict such behavior in this subtype of lymphoid malignancy.",
author = "Louis Picker and Medeiros, {L. J.} and Weiss, {L. M.} and Warnke, {R. A.} and Butcher, {E. C.}",
year = "1988",
language = "English (US)",
volume = "130",
pages = "498--504",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma

AU - Picker, Louis

AU - Medeiros, L. J.

AU - Weiss, L. M.

AU - Warnke, R. A.

AU - Butcher, E. C.

PY - 1988

Y1 - 1988

N2 - In man, lymphocyte binding to high endothelial venules (HEVs) involves specific 85-95-kd cell surface glycoprotein(s) recognized by the monoclonal antibodies Hermes-1 and Hermes-3. These putative 'homing receptor' molecule(s) are believed to play an important role in the normal regulation of lymphocyte circulation. To investigate the possibility that homing receptors alsy play a role in the biology of lymphoid malignancies, the authors studied over 300 cases of non-Hodgkin's lymphoma by immunohistologic staining with Hermes-1 and -3, antibodies that define two distinct epitopes on the gp 85-95 putative homing receptor molecules. Furthermore, they directly compared expression of the Hermes-3 antigen with clinical extent of disease in 57 patients with diffuse large cell lymphoma. They found that staining of the various subtypes of lymphoma was heterogeneous, and in general correlated with patterns of expression seen in benign lymphoid populations. Essentially all normal lymphoid populations examined, except germinal center B cells and most cortical thymocytes, bear a high level of homing receptor antigen. Similarly, nearly all peripheral T-cell lymphomas, diffuse small cell lymphomas of B lineage, and plasma cell tumors were positive for homing receptor antigen (95%, 97%, and 100% respectively). Small noncleaved cell, follicular, and diffuse large cell lymphomas of B lineage, tumors having morphologic or immunologic features resembling germinal center cells, frequently failed to express Hermes-defined epitopes (81%, 41%, 25% Hermes-3-, respectively). Antigen expression in T-lymphoblastic lymphomas strongly correlated with immunophenotypic subtypes: only 8% of CD4+/CD8+ were Hermes-1+ versus 86% of CD4-/CD8- and 43% of CD4+/CD8-. Hermes-3 expression by cases of diffuse, large cell lymphoma which showed generalized lymph node involvement (a pattern strongly suggestive of HEV-mediated spread; 100% Hermes-3+, mean intensity 3.4) was higher than that of cases with localized or multifocal, contiguous involvement (consistent with lymphatic spread; 69% Hermes-3+, mean intensity 2.2), but these differences did not achieve statistical significance. The results indicate that homing receptor antigen expression, although perhaps necessary for widespread blood-borne lymphoma dissemination to lymphoid sites, is not in and of itself sufficient to predict such behavior in this subtype of lymphoid malignancy.

AB - In man, lymphocyte binding to high endothelial venules (HEVs) involves specific 85-95-kd cell surface glycoprotein(s) recognized by the monoclonal antibodies Hermes-1 and Hermes-3. These putative 'homing receptor' molecule(s) are believed to play an important role in the normal regulation of lymphocyte circulation. To investigate the possibility that homing receptors alsy play a role in the biology of lymphoid malignancies, the authors studied over 300 cases of non-Hodgkin's lymphoma by immunohistologic staining with Hermes-1 and -3, antibodies that define two distinct epitopes on the gp 85-95 putative homing receptor molecules. Furthermore, they directly compared expression of the Hermes-3 antigen with clinical extent of disease in 57 patients with diffuse large cell lymphoma. They found that staining of the various subtypes of lymphoma was heterogeneous, and in general correlated with patterns of expression seen in benign lymphoid populations. Essentially all normal lymphoid populations examined, except germinal center B cells and most cortical thymocytes, bear a high level of homing receptor antigen. Similarly, nearly all peripheral T-cell lymphomas, diffuse small cell lymphomas of B lineage, and plasma cell tumors were positive for homing receptor antigen (95%, 97%, and 100% respectively). Small noncleaved cell, follicular, and diffuse large cell lymphomas of B lineage, tumors having morphologic or immunologic features resembling germinal center cells, frequently failed to express Hermes-defined epitopes (81%, 41%, 25% Hermes-3-, respectively). Antigen expression in T-lymphoblastic lymphomas strongly correlated with immunophenotypic subtypes: only 8% of CD4+/CD8+ were Hermes-1+ versus 86% of CD4-/CD8- and 43% of CD4+/CD8-. Hermes-3 expression by cases of diffuse, large cell lymphoma which showed generalized lymph node involvement (a pattern strongly suggestive of HEV-mediated spread; 100% Hermes-3+, mean intensity 3.4) was higher than that of cases with localized or multifocal, contiguous involvement (consistent with lymphatic spread; 69% Hermes-3+, mean intensity 2.2), but these differences did not achieve statistical significance. The results indicate that homing receptor antigen expression, although perhaps necessary for widespread blood-borne lymphoma dissemination to lymphoid sites, is not in and of itself sufficient to predict such behavior in this subtype of lymphoid malignancy.

UR - http://www.scopus.com/inward/record.url?scp=0023976094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023976094&partnerID=8YFLogxK

M3 - Article

VL - 130

SP - 498

EP - 504

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 3

ER -